[Federal Register: November 6, 2001 (Volume 66, Number 215)]
[Notices]               
[Page 56088]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06no01-37]                         

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army

 
Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Pharmaceutical 
Composition Containing pGLU-GLU-PRO-NH2 and Method for Treating 
Diseases and Injuries to the Brain, Spinal Cord and Retina Using Same

AGENCY: Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent Application No. 09/692,938 
entitled ``Pharmaceutical Composition Containing pGLU-GLU-PRO-NH2 and 
Method for Treating Diseases and Injuries to the Brain, Spinal Cord and 
Retina Using Same'' and filed October 20, 2000. Foreign rights are also 
available (PCT/US00/29278). The United States Government, as 
represented by the Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: A neuroprotectant composition wherein the 
active ingredient is pGLU-GLU-PRO-NH2 or a combination of pGLU_GLU-PRO-
NH2 (EEP) and N-tert-Butyl--(2sulfophenyl)nitrone (SPBN) or 
other nitrone. A method of treating and preventing diseases and 
injuries of the brain, spinal cord and retina is also presented by 
administering the endogenous tripeptide EEP to a subject as a 
neuroprotectant or by administering EEP in combination with SPBN or 
other nitrone.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 01-27864 Filed 11-5-01; 8:45 am]
BILLING CODE 3710-08-M